A detailed history of Price T Rowe Associates Inc transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 582,275 shares of CABA stock, worth $2.56 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
582,275
Previous 612,398 4.92%
Holding current value
$2.56 Million
Previous $10.4 Million 58.3%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$7.22 - $18.82 $217,488 - $566,914
-30,123 Reduced 4.92%
582,275 $4.36 Million
Q1 2024

May 15, 2024

BUY
$16.79 - $25.38 $1.42 Million - $2.15 Million
84,633 Added 16.04%
612,398 $10.4 Million
Q4 2023

Feb 14, 2024

BUY
$12.21 - $23.36 $6.26 Million - $12 Million
512,450 Added 3346.07%
527,765 $12 Million
Q3 2023

Nov 14, 2023

BUY
$11.84 - $18.65 $32,252 - $50,802
2,724 Added 21.63%
15,315 $234,000
Q2 2023

Aug 14, 2023

BUY
$7.65 - $13.95 $96,321 - $175,644
12,591 New
12,591 $163,000

Others Institutions Holding CABA

About Cabaletta Bio, Inc.


  • Ticker CABA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,014,000
  • Market Cap $127M
  • Description
  • Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...
More about CABA
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.